COLLEGE PARK, Md. (EGMN) The Food and Drug Administrations Cardiovascular and Renal Drugs Advisory Committee on July 28 voted 7-1 to recommend approval of the platelet inhibitor ticagrelor to treat nonST elevation myocardial infarction and ST-elevation myocardial infarction in patients intended to receive primary coronary intervention or who would be managed medically.
Extending the time window for giving the recombinant tissue plasminogen activator alteplase toischemic stroke patients has increased the percentage of patients who are eligible to receive the thrombolytic therapy without causing treatment delays, according to a study published online July 27 in Lancet Neurology.
A Rhode Island Department of Health investigation into the use of unapproved versions of common intrauterine devices has prompted the Food and Drug Administration to launch its own probe, and warn doctors against purchasing IUDs that have not received specific FDA approval.
WASHINGTON (EGMN) Direct-to-consumer genetic tests are deceptively marketed and often give misleading results that are of little or no practical use, said the U.S. Government Accountability Office in a report released on July 22 at a hearing of the House Energy and Commerce Committees Subcommittee on Oversight and Investigations.
High-density lipoprotein cholesterol concentrations are inversely associated with risk for cardiovascular events, but this association does not persist in patients who achieve very low concentrations of low-density lipoprotein cholesterol on statin therapy, according to an analysis of data from the JUPITER trial.
The relationship between intranasal zinc gluconate gel and anosmia meets criteria for causality, according to the findings of a literature review and an observational published in the July Archives of Otolaryngology Head and Neck Surgery.
Patients could gain greater access to their health information and have more power to limit disclosures of certain personal information to health plans under a new proposal from the Health and Human Services department.
Inhalers stolen from a GlaxoSmithKline warehouse in Virginia have started to turn up for sale at some pharmacies, the Food and Drug Administration announced on July 16.
New health plans will soon be required to offer a range of recommended preventive health services to patients free of charge under the Affordable Care .
Intranasal insulin boosted cognitive function and even brain activity in patients with mild cognitive impairment and early Alzheimers disease in a 4-month, randomized, placebo-controlled trial.
